There are some skin conditions we're very familiar with: spots during adolescence, allergic rashes, sunburn. But others are ...

Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential ...

Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential ...

Patients with rosacea and skin of color are more likely to have severe disease phenotypes when compared with White patients with rosacea.

The company plans to reduce gross-to-net discounts from 46%-49% in Q1 to the low 40s by Q4. A Phase II study for ocular rosacea is set to begin in late 2025, with data expected in 2026. Tarsus aims to ...

A Phase II study for ocular rosacea is set to begin in late 2025, with data expected in 2026. Tarsus aims to expand physician education to identify Demodex blepharitis in broader patient categories.

EIMs occur in up to 25% to 40% of people with IBD. The exact cause of ocular symptoms in Crohn’s disease isn’t known. But there’s growing evidence of a genetic component. A family history of ...

Rosacea is categorized into 4 main subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular. Each subtype is distinguished by common patterns and symptoms. Subtype 1 ...

“The results of these placebo-controlled randomized clinical trials demonstrate that minocycline is efficacious and provides significantly superior outcomes in rosacea compared with placebo and ...

IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27 th Annual Global ...

If you have rosacea, you must be experiencing redness and small, red bumps on your face for a long time. These symptoms may last for a few weeks or months and then disappear for a while. The problem ...

and ocular manifestations. Among the more recently approved treatments for rosacea — and among products and drug indications under study — “notice there’s a paucity of antibiotics ...